RxDoctor Payments DataLook up a doctor →

Michael Cameron

Dermatology · New York, NYNPI 1912391186

Payments from drug & device makers

$5,773,890in general payments, 2019–2025

Across 3,824 payments — averaging $1509.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi US Services Inc.$1.9M
  • AbbVie$1M
  • Eli Lilly$361K
  • Lilly USA, LLC$263K
  • Novartis$260K
  • Dermavant Sciences, Inc.$221K
  • plus $1.7M from 31 others
$32,090in research payments, 2019–2025

Across 17 payments — averaging $1887.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$27K
  • Eli Lilly$5K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi US Services Inc.98$1,924,279
AbbVie(2 entities)743$1,004,590
Eli Lilly9$360,624
Lilly USA, LLC351$263,486
Novartis49$260,063
Dermavant Sciences, Inc.258$221,151
Incyte Corporation275$218,852
E.r. Squibb & Sons, L.L.C.222$201,153
Sanofi154$189,044
Amgen195$180,658
Regeneron Healthcare Solutions, Inc.194$168,477
UCB, Inc.233$166,459
Sun Pharmaceutical Industries Inc.165$157,633
LEO Pharma Inc.221$154,332
Arcutis Biotherapeutics, Inc.128$76,922
Galderma Laboratories, L.p.130$76,428
Organon46$58,931
Pfizer56$33,586
Verrica Pharmaceuticals Inc.41$23,228
Ortho Dermatologics, A Division Of Bausch Health US, LLC100$15,185
Johnson & Johnson76$9,530
Kowa Pharmaceuticals America, Inc.2$2,625
Journey Medical Corporation22$1,981
Botanix SB Inc14$1,892
EPI Health, LLC3$1,537
Merz North America, Inc.2$325
Biofrontera Inc.8$249
Almirall LLC9$185
Krystal Biotech Inc6$115
Mayne Pharma Commercial LLC5$113
Biogen1$70
VYNE Pharmaceuticals Inc.2$46
Takeda Pharmaceuticals U.S.A., Inc.1$35
Kyowa Kirin, Inc.2$33
Mallinckrodt Hospital Products Inc.1$32
Janssen Scientific Affairs, LLC1$25
LNHC, Inc1$20

How this compares

$5,773,890 in reported general payments places this provider in the 95th percentile of 1,151 dermatology providers in New York.

See all dermatology providers in New York →

Medicare billing

Part B allowed, 2024
$404,936
Medicare patients
537
Services billed
8,887

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →